Tissue plasminogen activator (t-PA). Will it fulfill its promise?
D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D012008:Recurrence; D013300:Streptokinase / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator